Subscribe to RSS
DOI: 10.1055/s-0034-1372429
In Utero Repair of Spina Bifida
Publication History
31 December 2013
10 February 2014
Publication Date:
12 May 2014 (online)
Abstract
Open spina bifida or myelomeningocele (MMC) is the most common congenital malformation of the central nervous system compatible with long-term survival and is associated with significant lifelong disabilities. Postnatal care of MMC involves covering the exposed spinal cord, infection prevention, and ventricular shunting for hydrocephalus. The aim of postnatal MMC surgery is not to reverse or prevent the neurologic injury seen in MMC, but to palliate. The neurologic defects result from primary incomplete neurulation and secondary chronic in utero damage to the exposed neural elements through mechanical and chemical trauma—the two-hit hypothesis. With the ability to accurately diagnose spina bifida prenatally and the concept of the two-hit hypothesis, in utero repair to decrease exposure and alter the antenatal course of neurologic destruction was conceived. Through animal models and human pilot studies, the feasibility of fetal spina bifida repair was demonstrated. Subsequently, the prospective randomized multicenter Management of Myelomeningocele Study (MOMS trial) revealed a decreased need for shunting, reversal of hindbrain herniation, and preservation of neurologic function, making in utero repair an accepted care alternative for select women carrying a fetus with spina bifida. This article will highlight the background and rationale for in utero repair, and the progression to becoming an alternative standard of care. The future directions of fetal spina bifida repair will also be addressed.
-
References
- 1 Shin M, Kucik JE, Siffel C , et al. Improved survival among children with spina bifida in the United States. J Pediatr 2012; 161 (6) 1132-1137
- 2 Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 2001; 34 (3) 114-120
- 3 Rintoul NE, Sutton LN, Hubbard AM , et al. A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 2002; 109 (3) 409-413
- 4 Caldarelli M, Di Rocco C, La Marca F. Shunt complications in the first postoperative year in children with meningomyelocele. Childs Nerv Syst 1996; 12 (12) 748-754
- 5 Just M, Schwarz M, Ludwig B, Ermert J, Thelen M. Cerebral and spinal MR-findings in patients with postrepair myelomeningocele. Pediatr Radiol 1990; 20 (4) 262-266
- 6 Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet 2004; 364 (9448) 1885-1895
- 7 Cochrane DD, Wilson RD, Steinbok P , et al. Prenatal spinal evaluation and functional outcome of patients born with myelomeningocele: information for improved prenatal counselling and outcome prediction. Fetal Diagn Ther 1996; 11 (3) 159-168
- 8 Drennan JC. Foot deformities in myelomeningocele. In: Thilos HS, , ed. Instructional Course Lectures. Park Ridge, IL: American Academy of Orthopedic Surgeons; 1991
- 9 Cass AS, Luxenberg M, Johnson CF, Gleich P. Incidence of urinary tract complications with myelomeningocele. Urology 1985; 25 (4) 374-378
- 10 Northrup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr 2000; 30 (10) 313-332
- 11 Vachha B, Adams R. Language differences in young children with myelomeningocele and shunted hydrocephalus. Pediatr Neurosurg 2003; 39 (4) 184-189
- 12 Lavigne JV, Faier-Routman J. Psychological adjustment to pediatric physical disorders: a meta-analytic review. J Pediatr Psychol 1992; 17 (2) 133-157
- 13 Holmbeck GN, Devine KA. Psychosocial and family functioning in spina bifida. Dev Disabil Res Rev 2010; 16 (1) 40-46
- 14 Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol 2010; 52 (8) 749-753
- 15 Oakeshott P, Hunt GM. Long-term outcome in open spina bifida. Br J Gen Pract 2003; 53 (493) 632-636
- 16 Centers for Disease Control and Prevention (CDC). Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects—United States, 2003. MMWR Morb Mortal Wkly Rep 2007; 56 (2) 25-29
- 17 Radcliff E, Cassell CH, Tanner JP , et al. Hospital use, associated costs, and payer status for infants born with spina bifida. Birth Defects Res A Clin Mol Teratol 2012; 94 (12) 1044-1053
- 18 Cassell CH, Grosse SD, Thorpe PG, Howell EE, Meyer RE. Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina. Birth Defects Res A Clin Mol Teratol 2011; 91 (12) 1019-1027
- 19 Ouyang L, Grosse SD, Armour BS, Waitzman NJ. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol 2007; 79 (7) 552-558
- 20 Dicianno BE, Wilson R. Hospitalizations of adults with spina bifida and congenital spinal cord anomalies. Arch Phys Med Rehabil 2010; 91 (4) 529-535
- 21 Parker SE, Mai CT, Canfield MA , et al; National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 2010; 88 (12) 1008-1016
- 22 Boulet SL, Yang Q, Mai C , et al; National Birth Defects Prevention Network. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol 2008; 82 (7) 527-532
- 23 Agopian AJ, Tinker SC, Lupo PJ, Canfield MA, Mitchell LE ; National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol 2013; 97 (1) 42-46
- 24 Centers for Disease Control (CDC). Use of folic acid for prevention of spina bifida and other neural tube defects—1983-1991. MMWR Morb Mortal Wkly Rep 1991; 40 (30) 513-516
- 25 CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992; 41 (RR–14, No. RR–14): 1-7
- 26 Brock DJ, Bolton AE, Monaghan JM. Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement. Lancet 1973; 2 (7835) 923-924
- 27 Vince JD, McManus TJ, Ferguson-Smith MA, Ratcliffe JG. A semi-automated serum alphafetoprotein radioimmunoassay for prenatal spina bifida screening. Br J Obstet Gynaecol 1975; 82 (9) 718-727
- 28 Macri JN, Weiss RR, Schell NB, Abrahams I, Starkovsky NA. Progress in screening for neural tube defects. JAMA 1977; 237 (20) 2187
- 29 Loft AG, Høgdall E, Larsen SO, Nørgaard-Pedersen B. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects. Prenat Diagn 1993; 13 (2) 93-109
- 30 Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol 1999; 94 (4) 562-566
- 31 Adzick NS, Thom EA, Spong CY , et al; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364 (11) 993-1004
- 32 Hutchins GM, Meuli M, Meuli-Simmen C, Jordan MA, Heffez DS, Blakemore KJ. Acquired spinal cord injury in human fetuses with myelomeningocele. Pediatr Pathol Lab Med 1996; 16 (5) 701-712
- 33 Meuli M, Meuli-Simmen C, Hutchins GM, Seller MJ, Harrison MR, Adzick NS. The spinal cord lesion in human fetuses with myelomeningocele: implications for fetal surgery. J Pediatr Surg 1997; 32 (3) 448-452
- 34 Korenromp MJ, van Gool JD, Bruinese HW, Kriek R. Early fetal leg movements in myelomeningocele. Lancet 1986; 1 (8486) 917-918
- 35 Sival DA, Begeer JH, Staal-Schreinemachers AL, Vos-Niël JM, Beekhuis JR, Prechtl HF. Perinatal motor behaviour and neurological outcome in spina bifida aperta. Early Hum Dev 1997; 50 (1) 27-37
- 36 Luthy DA, Wardinsky T, Shurtleff DB , et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med 1991; 324 (10) 662-666
- 37 Shurtleff DB, Luthy DA, Nyberg DA, Benedetti TJ, Mack LA. Meningomyelocele: management in utero and post natum. Ciba Found Symp 1994; 181: 270-280 , discussion 280–286
- 38 Michejda M. Intrauterine treatment of spina bifida: primate model. Z Kinderchir 1984; 39 (4) 259-261
- 39 Heffez DS, Aryanpur J, Rotellini NA, Hutchins GM, Freeman JM. Intrauterine repair of experimental surgically created dysraphism. Neurosurgery 1993; 32 (6) 1005-1010
- 40 Heffez DS, Aryanpur J, Hutchins GM, Freeman JM. The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 1990; 26 (6) 987-992
- 41 Meuli M, Meuli-Simmen C, Yingling CD , et al. Creation of myelomeningocele in utero: a model of functional damage from spinal cord exposure in fetal sheep. J Pediatr Surg 1995; 30 (7) 1028-1032 , discussion 1032–1033
- 42 Meuli M, Meuli-Simmen C, Hutchins GM , et al. In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med 1995; 1 (4) 342-347
- 43 Paek BW, Farmer DL, Wilkinson CC , et al. Hindbrain herniation develops in surgically created myelomeningocele but is absent after repair in fetal lambs. Am J Obstet Gynecol 2000; 183 (5) 1119-1123
- 44 Bouchard S, Davey MG, Rintoul NE, Walsh DS, Rorke LB, Adzick NS. Correction of hindbrain herniation and anatomy of the vermis after in utero repair of myelomeningocele in sheep. J Pediatr Surg 2003; 38 (3) 451-458 , discussion 451–458
- 45 Bruner JP, Tulipan NE, Richards WO. Endoscopic coverage of fetal open myelomeningocele in utero. Am J Obstet Gynecol 1997; 176 (1 Pt 1) 256-257
- 46 Tulipan N, Hernanz-Schulman M, Bruner JP. Reduced hindbrain herniation after intrauterine myelomeningocele repair: A report of four cases. Pediatr Neurosurg 1998; 29 (5) 274-278
- 47 Adzick NS, Sutton LN, Crombleholme TM, Flake AW. Successful fetal surgery for spina bifida. Lancet 1998; 352 (9141) 1675-1676
- 48 Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 1999; 282 (19) 1826-1831
- 49 Bruner JP, Tulipan N, Paschall RL , et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282 (19) 1819-1825
- 50 Johnson M , the MOMS Investigators. Risk factors for preterm delivery and uterine dehiscence following prenatal surgery for myelomeningocele. Am J Obstet Gynecol 2012; 206 (Suppl 1): S198
- 51 American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 550: Maternal-Fetal Surgery for Myelomeningocele. Obstet Gynecol 2013; 121 (1) 218-219
- 52 Wilson RD, Lemerand K, Johnson MP , et al. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996-2007). Am J Obstet Gynecol 2010; 203 (3) e1-e6
- 53 Werner EF, Han CS, Burd I , et al. Evaluating the cost-effectiveness of prenatal surgery for myelomeningocele: a decision analysis. Ultrasound Obstet Gynecol 2012; 40 (2) 158-164
- 54 Simpson JL, Greene MF. Fetal surgery for myelomeningocele?. N Engl J Med 2011; 364 (11) 1076-1077
- 55 Cohen AR, Couto J, Cummings JJ , et al; MMC Maternal-Fetal Management Task Force. Position statement on fetal myelomeningocele repair. Am J Obstet Gynecol 2014; 210 (2) 107-111
- 56 Johnson MP ; NAFTNet. The North American Fetal Therapy Network (NAFTNet): a new approach to collaborative research in fetal diagnosis and therapy. Semin Fetal Neonatal Med 2010; 15 (1) 52-57
- 57 Verbeek RJ, van der Hoeven JH, Sollie KM , et al. Muscle ultrasound density in human fetuses with spina bifida aperta. Early Hum Dev 2009; 85 (8) 519-523
- 58 Verbeek RJ, van der Hoeven JH, Maurits NM, Brouwer OF, Hoving EW, Sival DA. In spina bifida aperta, muscle ultrasound can quantify the “second hit of damage”. Childs Nerv Syst 2013; 29 (3) 469-474
- 59 Kohl T, Tchatcheva K, Merz W , et al. Percutaneous fetoscopic patch closure of human spina bifida aperta: advances in fetal surgical techniques may obviate the need for early postnatal neurosurgical intervention. Surg Endosc 2009; 23 (4) 890-895
- 60 Verbeek RJ, Heep A, Maurits NM , et al. Fetal endoscopic myelomeningocele closure preserves segmental neurological function. Dev Med Child Neurol 2012; 54 (1) 15-22
- 61 Peiro JL, Fontecha CG, Ruano R , et al. Single-Access Fetal Endoscopy (SAFE) for myelomeningocele in sheep model I: amniotic carbon dioxide gas approach. Surg Endosc 2013; 27 (10) 3835-3840
- 62 Watanabe M, Jo J, Radu A, Kaneko M, Tabata Y, Flake AW. A tissue engineering approach for prenatal closure of myelomeningocele with gelatin sponges incorporating basic fibroblast growth factor. Tissue Eng Part A 2010; 16 (5) 1645-1655
- 63 Watanabe M, Li H, Roybal J , et al. A tissue engineering approach for prenatal closure of myelomeningocele: comparison of gelatin sponge and microsphere scaffolds and bioactive protein coatings. Tissue Eng Part A 2011; 17 (7-8) 1099-1110